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Abstract 
It has recently been reported that whole skeletal development is normal or even increased in 
spontaneously hypertensive (SH) rats compared to normotensive controls (DeMoss and Wright, 
1998). Using the 3H-tetracycline model, whole body skeletal bone resorption was compared 
' 
between male and female hypertensive SH and normotensive Wistar Kyoto (WKy) and Sprague-
Dawley (SD) rats. An indication of significantly elevated resorption, both in terms of iate of 
resorption and extent of metabolically reactive bone, was detected in SH rats at 8 weeks of age. 
In mature animals (24 week old) the rate ofresorption (52% to 135%) and extent of 
metabolically reactive bone (39% to 88%) were significantly elevated in females comp~red to 
' 
males in each of the three rat strains studied. In within sex comparisons of 24 week 014 animals, 
the bone resorptive activity was similar in normotensive WKy and SD groups. By comparison, 
the resorptive activity of both male and female SH rats was significantly increased com~ared to 
normotensive controls. This was particularly true in female SH rats which showed 40% and 78% 
elevation in rate of resorption and extent of metabolically reactive bone, respectively, in 
comparison with normotensive female controls. In light of normal or enhanced skeletal 
development in SH rats, the present results indicate a dramatically higher level of bone turnover 
in hypertensives that is detectable as early as eight weeks of age. 
Index Terms: Skeleton, resorption, bone, SHR, hypertension 
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Introduction 
There is substantial indirect evidence suggesting a possible link between hypertension and 
osteoporotic disease. High levels of PTH are seen in osteoporotic (9) and hypertensive patients 
(20). Patients with osteoporosis often exist in a hyperparathyroid state (4, 24) and it is reported 
that a large portion of individuals with osteoporosis have blood pressure greater than normal (10, 
15). Patients with essential hypertension as well as animal models of hypertension (SHR) show 
decreased JJlasma ionic calcium, increased PTH, and increased urinary excretion of calcium (16, 
18, 20, 26). Blood pressure in both humans and SHR is reduced by parathyroidectomy; whereas, 
' ' 
increased dietary calcium has been shown to both delay the onset and reduce the severity of 
' 
hypertension (1, 3, 17). Hence, it may be reasonable to speculate that bone metabolism is altered 
in hypertension where PTH is elevated and calcium metabolism is abnormal. 
Experimental evaluation of bone metabolism in hypertension is limite!i. Earlier studies indicated 
bone calcium content (5, 19) was not different between SHR and normotensive animals. Other 
studies; however, found evidence of decreased cortical bone mass and increased numbers of 
osteoclasts in the hypertensive rat ( 12, 22). More recently, evidence for decreased trabecular 
bone volume and increased bone turnover has been reported for SHR (2, 25). Hence;results 
from the study of individual bones are generally consistent with increased bone turnover leading 
to bone loss in older hypertensive animals. It has been demonstrated in whole animal studies; 
however, that development of skeletal mass in SH rats is normal or enhanced compared to 




compare skeletal resorptive activity between SH and two normotensive rat strains. Thtb results 
' 
indicate a marked increase of skeletal bone resorption in hypertension that is apparent in both 
young growing animals as well as in mature rats. 
Materials and Methods 
The animals utilized were Sprague-Dawley (SD/HlaBR, Hilltop Lab Animals, Scottsdale, PA), 
Wistar Kyoto (WKy/NCr!BR, Charles River, Wilmington, MA), and Aoki-Okamoto, ' 
spontaneously hypertensive rats (SHR/NCr!BR, Charles River, Wilmington, MA). Animals 
were maintained in colony rooms at 23 ± 2 °C on a 12h light/dark photoperiod and were allowed 
free access to Purina Rat Chow and tap water. The systolic blood pressure of selected groups of 
rats from each strain was measured with the animal conscious using a programmed 
electrosphygmomanometer with pneumatic pulse transducer and tail-cuff. 
iH-Tetracycline Method for Measnrement of Whole Skeleton Bone Resorption. Whole 
skeleton bone resorption was measured as previously described ( 6). Thirteen days prior to the 
start of urine collection a total of 12 male and 12 female rats of each of the SH, WKy and SD 
' 
strains at either 6 weeks or 22 weeks of age underwent a series of subcutaneous injections of 3H-
tetracycline (NET-141 Tetracycline, [7-3HCN]; New England Nuclear, Boston MA) dissolved in 
0.05 M HCl containing ascorbic acid as a reducing agent. At the end of the isotope labrling 
period, 8 week old rats had received a total of 25 µCi/rat in five injections while 24 we~k old rats 





Following the final injection, each rat was transferred to a standard metabolic chamber
1
and its 
food consumption and body weight were monitored daily. The first 24-h urine was discarded 
and the urine was collected thereafter at 24-h intervals for a period of 35 days. Urine vplume 
was recorded daily and a 0.5 ml aliquot from each sample was combined with 10 ml of 
Scintiverse E (Fisher Scientific; Pittsburgh, PA) to determine 3H-tetracycline content by liquid 
scintillation spectrometry. The relationship between body mass and dry skeletal mass previously 
determined for each of the rat strains (7) was utilized to normalize the urinary 3-H-tetra<;:ycline 
loss curve data for the dry skeletal mass of each rat at the end of isotope injection. Individual 
curves were then analyzed by Table Curve 2D Automated Curve Fitting Software (Jandel 
Scientific, San Rafael, CA). Based on the equation obtained, the curves were further arialyzed to 
I 
obtain the following parameter for the slow compartment of label loss which is thought1to 
represent cell-mediated bone resorption; (!) y-intercept, the rate oflabel loss from the actively 
I 
resorbing bone compartment immediately following termination of label loading. This , 
parameter provides a measure of the rate of resorption uncomplicated by previous depl~tion of 
label from resorbing bone; (2) area under the curve or pool size, this parameter serves as a 
measure of the extent of metabolically reactive bone; (3) 't, an estimate ofx-intercept which 
represents the time constant for 63% depletion of the labeled pool (5 't, the depletion ti~e, equals 
the number of days required for> 98% pool label turnover). This parameter reflects the 
proportionality of the interaction ofrate of resorption and pool size. For example, a de~rease in 
I 
depletion time would indicate greater rate of resorption relative to pool size. 
Statistics 
'1 
The regression parameters were analyzed for significant difference via Three Factor ANOV A 
I 
(Super ANOVA:Abacus Concepts, Berkeley, CA). Differences were considered signiflcant if 
P < 0.05. Data are presented as mean± SEM throughout the text. 
Results 
6 
Figure 1 shows the pattern of blood pressure development of SH and normotensive WK.y and SD 
rats in the interval from 8 to 24 weeks of age. Both male and female SH rats showed el,evation of 
blood pressure to hypertensive levels by 8 weeks of age. Thereafter, blood pressure coltinued to 
i 
I 
increase with severe hypertension realized in 24 week old animals. The blood pressure! 
development in WK.y, the parent strain of SHR (23), and SD rats also increased with maturity but 
were well below that ofSHR. Each of the rat strains investigated showed a dichotomy ?fblood 
I 
pressure development between sexes, with the values obtained in females significantly lower 
than those of males. 
Skeletal Resorption Kinetic Parameters. Significant differences were observed among rapidly 
I 
I 
growing 8 week old animals of the three rat strains in both the rate ofresorption (Table [)and 
pool size (Table 2). WK.y values tended to be higher than SD values; however, the rate ~f 
resorption and pool size in both male and female SHR was significantly increased comp:ared to 
! 
either the WK.y or SD groups. The increase of both of these parameters in SHR relative!to 
, / 
7 
controls was such that pool depletion time (Table 3) was reduced in both male (10% to 24%) and 
I 
females (19%). Although rate ofresorption and pool size tended to be reduced in females 
I 
! 
compared to males there was no consistent evidence of sexual dichotomy in resorption: 
parameters at 8 weeks of age. 
There was a dramatic decrease in male values for rate ofresorption (60% to 70%) and pool size 
(75% to 80%) between 8 and 24 weeks of age. Female values also decreased for rate of 
resorption (15% to 35%) and pool size ( 45% to 60%) but to a lesser extent than seen in males. In 
24 week old animals there was a clear sexual dichotomy with elevated female rate of resorption 
and pool size recorded for each of the three rat strains. Within sex comparisons indicated no 
differences in rate of resorption (Table 1 ), pool size (Table 2) or depletion time (Table 3) 
between normotensive 24 week old WKy and SD rats. Male SHR showed significantly 
increased rate of resorption compared to both WKy and SD rats at 24 weeks. Pool size of24 
' 
week old male SHR was also increased relative to SD rats; whereas, no significant difference in 
depletion time was evident among males of the three rat strains. By comparison 24 week old 
female SHR showed consistently increased resorption values compared to both the normotensive 
WKy and SD controls. In addition, the depletion time of female SHR was significantly reduced, 
reflecting a disproportionate elevation in rate of resorption. 
8 
Discussion 
The spontaneously hypertensive rat (SHR) is a widely studied model of essential hypel)tension 
that exhibits similar properties of abnormal calcium metabolism to those seen in humfili . ' 
hypertensives. Urinary calcium loss is increased in SHR with hypercalcuira reported by 17 
weeks of age in males with associated decreased serum ionized calcium and elevated PTH levels 
(14). Although still an area of controversy, there is an extensive literature suggesting that 
gastrointestinal handling of calcium is significantly altered in SHR (reviewed in 11). Taken 
together, the literature clearly indicates significant disturbance of various factors regulating 
calcium metabolism in hypertension that could affect bone mineral metabolism. 
Depletion time may serve as an indicator of the proportionality between the rate or inten~ity of 
cell-mediated resorptive activity and the pool size or extent of metabolically reactive bo11e. For 
example, both the rate of resorption and pool size decreased dramatically between 8 and ?4 
weeks of age indicating a significant overall decrease in resorptive function in mature animals. 
However, this was accompanied by a corresponding decrease in depletion times indicating that 
the shrinkage in pool size (males, 77%; females, 56%) was disproportionately high relative to the 
' 
decrease in rate or intensity ofresorptive function (males, 63%; females, 26%). Hence, the 
strategy for reduced resorption in mature animals appears to center on a reduction in extent of 
metabolically reactive bone although the rate or intensity of resorption may vary within this 
smaller compartment. At 24 weeks of age, female rats showed both less reduction in pool, size 
' 
and exaggerated disproportionality ofreduction in rate ofresorption compared to males. This 
I 
9 
pattern was particularly pronounced in female SHR. 
Various studies to evaluate individual bone densities (13, 21) ash weights (12) and 
histomorphormetric characteristics (25, 27) are generally consistent with increased bone 
catabolism and reduced bone mineralization in mature SHR. In recognition of the potential 
danger in extrapolating individual bone data to the intact skeleton, a recent study examined 
' 
whole skeletal dry weight and calcium content of SHR in comparison to WKy and SD rats (7). It 
was found that skeletal development. expressed as dry skeletal mass percent of body weight, was 
significantly increased in the females of each strain at both 8 weeks (- 25%) and 24 weeks (-
35%) of age. Within sex comparisons further indicated that skeletal development of SHR was 
significantly increased compared to WKy and SD controls in 24 week old males and in females 
at both 8 weeks and 24 weeks of ages. Moreover, they showed that the calcium content per gram 
of bone was identical among the three rat strains. Hence, whole body assessment indica,ted 
robust skeletal development and normal calcium content in skeletons of females compared to 
males and in hypertensive versus normotensive rats. Together with the present findings of 
elevated whole skeletal bone resorption, these results indicate that turnover, both bone formation 
and resorption, are markedly increased in hypertensive rats. 
The results indicate strong between-sex differences in mature animals with females exhibiting 
' 
I 
both increased rate of resorption (Table 1) and pool size (Table 2) compared to males. The 
I 
reason for increased resorptive activity in females is uncertain. The turnover of bone in rats at 24 
' 
weeks of age would be expected to involve significant remodeling and modeling activiti\!s 
• 
associated with repair and bone sculpting (8). In addition, skeletal bone turnover represents a 
I 
major mechanism in extracellular fluid calcium homeostasis. Because it seems unlikely that 
remodeling or modeling would be elevated in unbred females compared to males, a likely 
' 
explanation is that the increased resorptive activity is, in some fashion, linked to calcium 
homeostasis in the female. This, in tum, would appear consistent with the exacerbation of the 
phenomenon in SHR which exhibit evidence of disturbed calcium homeostasis. 
10 
In summary, a comparison among SH. WK.y and SD rat strains indicated, as expected, 1that whole 
body skeletal bone resorption was dramatically reduced between rapidly growing 8 week old and 
mature 24 week old animals. It was further found that in mature animals, whole skeletal 
resorptive activity was significantly elevated in females of each strain, compared to males. An 
increase in resorptive activity in SH rats compared to normotensive animals was detect.ed as early 
as 8 weeks of age. Increased resorption was clearly present in hypertensives at 24 wee~s of age 
and was particularly severe in female SHR. The cause of increased bone turnover in females or 
hypertensives is not certain but may be linked to the demands of whole body calcium 
homeostasis in these animals. In light of previous work (7), the results are suggestive that the 
stress placed on the skeleton by calcium homeostasis could be a major factor to increase skeletal 
mass in the mature animal in circumstances where adequate dietary calcium is available. On the 
other hand, the high basal level of bone turnover in female and hypertensive animals would be 
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34.3 ± 1.l*t 
5.8 ± 0.6 





14.9 ± 1.8 
18.9 ± 0.8" 
32.7 ± 1.4*t 
12.9 ± 0.6" 
12.5 ± 0.8" 








Data are presented as DPM/gm DSM x10-3, values indicate the average ±SEM of 6 animals 
* indicates significant difference from SD.,.value 
' indicates significant difference from WK.y value 




Table 2. 3H-tetracycline label pool size of 8 and 24 week old male and female SHR, WKy 
and SD rats. 
8Week 
Female Female/Male 
SD 532.0 ± 22.2 494.4± 32.8 0.92 
WKy 832.3 ± 19.5* 647.1±22.5"* 0.78 





SD 138.8 ± 10.8 260.I ± 5.7" 1.87 
' WKy 178.0 ± 11.0 248.0 ± 4.5" 1.39 
I 
SHR 205.2 ± I 0.3* 357.0 ± 20.2 "*' 1.74 
Data are presented as DPM/gm DSM x10·3, values indicate the average ±SEM of 6 apimals 
• significant difference between sexes of the same strain 
* significant difference from SD value 
t significant difference from WKy value 
• 
Table 3 .. Depletion time (days) for the 3H-tetracycline label from the skeleton of 8 and 24 








73.7 ± 3.7 
62.1 ± 1.8* 
56.0 ± 2.0* 
24 Week 
48.9± 1.8 
43.7 ± 2.3 
43.2± 2.7 
" indicates significant differences between sexes of the same strain 
* significant difference from SD value. 
+ significant difference from WKy value. 
Female 
68.5 ± 3.9 
68.6 ± 1.9 
55.3 ± 1.5*• 
40.7 ± 2.1" 
40.2 ± 2.0 
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Figure 1 Systolic blood pressure development in male and female spontaneously 
hypertensive (SH), Wistar Kyoto (WKy) and Sprague-Dawley (SD) rats 
between 8 weeks and 24 weeks of age. Values represent the average of six 
' 
animals. 
